Outcome of cell transfers into newborn Col7a1−/− mice
| Cell type . | Cell dose, 1 × 106 . | No. alive on day 21/no. injected (% alive) . |
|---|---|---|
| None | NA | 0/18 |
| MSC | 1 | 0/6 |
| MAPC | 0.5-1 | 0/48 |
| EpiSC | 1-5 | 0/20 |
| TAC | 5 | 0/8 |
| Nonenriched BM | 10 | 0/24 |
| BM CD150+48− | 8-10 | 3/20 (15%) |
| 1-5 | 0/34 | |
| BM CD150− | 8 | 0/7 |
| Cell type . | Cell dose, 1 × 106 . | No. alive on day 21/no. injected (% alive) . |
|---|---|---|
| None | NA | 0/18 |
| MSC | 1 | 0/6 |
| MAPC | 0.5-1 | 0/48 |
| EpiSC | 1-5 | 0/20 |
| TAC | 5 | 0/8 |
| Nonenriched BM | 10 | 0/24 |
| BM CD150+48− | 8-10 | 3/20 (15%) |
| 1-5 | 0/34 | |
| BM CD150− | 8 | 0/7 |
The indicated cell population and dose was given to Col7a1−/− mice intravenously between postnatal days 0 to 4.
MSC indicates mesenchymal stem cell; MAPC, multipotent adult progenitor cell; EpiSC, epidermal stem cell; TAC, transient amplifying cell; BM, bone marrow; and NA, not applicable.